Evidence map›Paper›PMID 32658535›Full record

ArticleExperimental and clinical psychopharmacology2021

An optimized procedure for robust volitional cocaine intake in mice.

Alberto J López, Amy R Johnson, Ansley J Kunnath, Allison D Morris, Jennifer E Zachry, Kimberly C Thibeault, Munir G Kutlu, Cody A Siciliano, Erin S Calipari

Open access · hybridAbstract read
In one paragraph

Article in Experimental and clinical psychopharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 10 citations in OpenAlex.

  1. GutGut microbes · 2026
    Article
  2. Synaptic plasticity in cocaine-seeking ensembles of the nucleus accumbens core.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Alberto J LópezDepartment of Pharmacology, Vanderbilt University/Vanderbilt University School of Medicine.ORCID 0000-0002-3149-2138
Amy R JohnsonDepartment of Pharmacology, Vanderbilt University/Vanderbilt University School of Medicine.
Ansley J KunnathVanderbilt University Medical Scientists Training Program, Vanderbilt University/Vanderbilt University School of Medicine.ORCID 0000-0001-6838-5056
Allison D MorrisDepartment of Pharmacology, Vanderbilt University/Vanderbilt University School of Medicine.ORCID 0000-0002-4557-8389
Jennifer E ZachryDepartment of Pharmacology, Vanderbilt University/Vanderbilt University School of Medicine.ORCID 0000-0002-4575-1276
Kimberly C ThibeaultDepartment of Pharmacology, Vanderbilt University/Vanderbilt University School of Medicine.
Munir G KutluDepartment of Pharmacology, Vanderbilt University/Vanderbilt University School of Medicine.
Cody A SicilianoDepartment of Pharmacology, Vanderbilt Center for Addiction Research, Vanderbilt University/Vanderbilt University School of Medicine.ORCID 0000-0001-9871-2089
Erin S CalipariDepartment of Pharmacology, Vanderbilt University/Vanderbilt University School of Medicine.ORCID 0000-0003-4723-0623
Vanderbilt University · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007347 · NIGMS · VANDERBILT UNIVERSITY · PI WILLIAMS, CHRISTOPHER S. · 1985 to 2023
$26.3M
TRAINING IN PHARMACOLOGICAL SCIENCEST32GM007628 · NIGMS · VANDERBILT UNIVERSITY · PI BARNETT, JOEY VICTOR, KAVALALI, EGE T · 1985 to 2022
$11.2M
Institutional Career Development CoreKL2TR002245 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Julie A. Bastarache · 2017 to 2026
$9.3M
Training in Fundamental NeuroscienceT32MH064913 · NIMH · VANDERBILT UNIVERSITY · PI IHRIE, REBECCA A, WINDER, DANNY G. · 2001 to 2022
$7.6M
Program in NeurogenomicsT32MH065215 · NIMH · VANDERBILT UNIVERSITY · PI ROGER J COLBRAN · 2002 to 2026
$6.4M
Medical Scientist Training ProgramT32GM152284 · NIGMS · VANDERBILT UNIVERSITY · PI Christopher S. Williams · 2024 to 2026
$4.8M
Mechanisms of dopaminergic dysfunction in substance use disorderR01DA052317 · NIDA · VANDERBILT UNIVERSITY · PI CALIPARI, ERIN · 2021 to 2025
$2.4M
Making and breaking opioid memories to prevent relapseDP1DA048931 · NIDA · VANDERBILT UNIVERSITY · PI CALIPARI, ERIN · 2019 to 2023
$2.4M
Defining the role of cortical circuit dynamics in learning and addictionR00DA045103 · NIDA · VANDERBILT UNIVERSITY · PI SICILIANO, CODY · 2020 to 2022
$764k
Defining the Role of D1 and D2 Medium Spiny Neurons in Relapse to Cocaine SeekingR00DA042111 · NIDA · VANDERBILT UNIVERSITY · PI CALIPARI, ERIN · 2018 to 2020
$747k
Defining the role of cortical circuit dynamics in learning and addictionK99DA045103 · NIDA · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI SICILIANO, CODY · 2018 to 2019
$366k
Defining the Role of D1 and D2 Medium Spiny Neurons in Relapse to Cocaine SeekingK99DA042111 · NIDA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CALIPARI, ERIN · 2016 to 2017
$301k
Brain and Behavior Research FoundationEdward Mallinckrodt Jr. FoundationNational Institute for Health ResearchNCATS NIH HHS KL2 TR002245NIDA NIH HHS DP1 DA048931NIDA NIH HHS F31 DA041838NIDA NIH HHS F31 DA050410NIDA NIH HHS F32 DA047777NIDA NIH HHS K00 DA048436NIDA NIH HHS K99 DA042111NIDA NIH HHS K99 DA045103NIDA NIH HHS R00 DA042111NIDA NIH HHS R00 DA045103NIDA NIH HHS R01 DA052317NIGMS NIH HHS T32 GM007347NIGMS NIH HHS T32 GM007628NIGMS NIH HHS T32 GM152284NIH HHSNIMH NIH HHS T32 MH064913NIMH NIH HHS T32 MH065215Whitehall Foundation
6 · The paper itself

Abstract

Substance use disorder (SUD) is a behavioral disorder characterized by volitional drug consumption. Mouse models of SUD allow for the use of molecular, genetic, and circuit-level tools, providing enormous potential for defining the underlying mechanisms of this disorder. However, the relevance of results depends on the validity of the mouse models used. Self-administration models have long been the preferred preclinical model for SUD as they allow for volitional drug consumption, thus providing strong face validity. While previous work has defined the parameters that influence intravenous cocaine self-administration in other species-such as rats and primates-many of these parameters have not been explicitly assessed in mice. In a series of experiments, we showed that commonly used mouse models of self-administration, where behavior is maintained on a fixed-ratio schedule of reinforcement, show similar levels of responding in the presence and absence of drug delivery-demonstrating that it is impossible to determine when drug consumption is and is not volitional. To address these issues, we have developed a novel mouse self-administration procedure where animals do not need to be pretrained on sucrose and behavior is maintained on a variable-ratio schedule of reinforcement. This procedure increases rates of reinforcement behavior, increases levels of drug intake, and results in clearer delineation between drug-reinforced and saline conditions. Together, these data highlight a major issue with fixed-ratio models in mice that complicates subsequent analysis and provide a simple approach to minimize these confounds with variable-ratio schedules of reinforcement. (PsycInfo Database Record (c) 2021 APA, all rights reserved).

Indexed as

CocaineReinforcement ScheduleSelf AdministrationAnimalsConditioning, OperantDose-Response Relationship, DrugFemaleMaleMiceMice, Inbred C57BLRatsReinforcement, PsychologyCocaine

Identifiers

PMID32658535
PMCPMC7890946
OpenAlexW3042766217

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.